Xospata 40 mg film-coated tablets
Phase 2 small_molecule active
Quick answer
Xospata 40 mg film-coated tablets for newly diagnosed non-M3 FLT3-positive acute myeloid leukemia is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- newly diagnosed non-M3 FLT3-positive acute myeloid leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active